Ideal Vial Size for Infliximab in the Treatment of Inflammatory Bowel Disease: An Analysis of Pharmaceutical Waste and Physician Opinions.

Jonathan M Schachne Laura L Durbin Corey R Lacher Maheep Sangha Anjali Mone Arun Swaminath

Published in: Crohn's & colitis 360 (2021)

Infliximab-prescribing gastroenterologists considered reducing drug waste as a common reason in their rounding practices. Our analysis demonstrates significant waste reduction and cost-savings are possible with the introduction of 50 and 25mg vials.

Keyphrases

primary care
heavy metals
sewage sludge
ulcerative colitis
municipal solid waste
life cycle
emergency department
healthcare
adverse drug
combination therapy
replacement therapy